Physician profile
Kelly J Smith
NPI 1528198405
$69,354.23
in general payments reported to CMS, 2019-2025
34 companies · $6,927 in 2025
The $6,927 reported for 2025 was more than what 96% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $2,867 · 2021: $5,611 · 2022: $5,369 · 2023: $16K · 2024: $14K · 2025: $6,927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Consulting Fee: $9,688 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,048 · Food and Beverage: $5,270 · Education: $208 · Travel and Lodging: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,845.00 |
| Consulting Fee | $9,687.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,048.00 |
| Food and Beverage | $5,269.94 |
| Education | $207.98 |
| Travel and Lodging | $123.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $43,956.23 | 2019-2025 | Nucala |
| Harmony Biosciences LLC | $13,290.97 | 2020-2025 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $5,415.16 | 2022-2023 | Ofev |
| Regeneron Healthcare Solutions, INC. | $1,387.38 | 2019-2025 | Dupixent |
| Astrazeneca Pharmaceuticals Lp | $1,006.05 | 2019-2025 | Tezspire, Fasenra |
| Jazz Pharmaceuticals INC. | $486.09 | 2019-2025 | |
| Baxter Healthcare | $482.26 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System, Hillrom - Synclara Cough System |
| Amgen INC. | $429.25 | 2022-2025 | Tezspire |
| Electromed, INC. | $396.39 | 2019-2025 | Smartvest |
| Biogen, INC. | $335.01 | 2019-2025 | Spinraza |
| Genzyme Corporation | $311.05 | 2021-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $277.69 | 2024-2025 | Lumryz |
| Philips North America LLC | $264.00 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Pharming Healthcare, INC. | $183.47 | 2023-2025 | Ruconest |
| Advanced Respiratory, INC | $154.37 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $122.60 | 2019-2023 | |
| Genentech USA, INC. | $115.35 | 2019-2023 | Xolair |
| Fisher & Paykel Healthcare INC | $103.77 | 2025 | Fisher & Paykel Healthcare |
| Itf Therapeutics LLC | $86.67 | 2024-2025 | |
| Phadia US INC. | $68.86 | 2024 | Immunocap |
| Covis Pharma Gmbh | $64.86 | 2021 | |
| Insmed, INC. | $64.13 | 2023-2025 | Arikayce |
| Tactile Systems Technology INC | $42.28 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.36 | 2023 | Elaprase, Cuvitru |
| Abbvie INC. | $41.26 | 2021-2022 | |
| Kaleo, INC. | $38.62 | 2020-2023 | Auvi-Q |
| Resmed Corp | $33.13 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $31.01 | 2019 | |
| 3b Medical, INC. | $28.01 | 2025 | Luna |
| Ars Pharmaceuticals Operations, INC. | $26.30 | 2025 | Neffy |
| Nestle Healthcare Nutrition INC. | $23.27 | 2021 | |
| Azurity Pharmaceuticals, INC. | $17.86 | 2025 | Alvesco |
| Lucid Diagnostics INC. | $15.82 | 2022 | |
| Regeneron Pharmaceuticals, INC. | $13.70 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.